- TheStreet.com•13 hours ago
Johnson & Johnson has been on a tear since late January. An overdue pullback may be on the way.
- TheStreet.com•14 hours ago
Abbott Laboratories appears poised to enjoy a fruitful year, though its litigation with former takeover target Alere could hold it back.
The U.S. Food and Drug Administration announced Tuesday a causal relationship between breast implants and a rare form of cancer, according to an NBC News report . The disease, a form of non-Hodgkin’s lymphoma ...
JNJ : Summary for Johnson & Johnson Common Stock - Yahoo Finance
Johnson & Johnson (JNJ)
NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
|Day's Range||126.21 - 127.65|
|52 Week Range||107.69 - 129.00|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||21.29|
|Dividend & Yield||3.20 (2.50%)|
|1y Target Est||N/A|